Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications

[1] Morrish DW(2009)Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial Arthritis Rheum 61 209-215

[2] Beaupre LA(2004)A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture Ann Intern Med 141 366-373

[3] Bell NR(2006)Measuring the impact of pharmacist intervention: results of patient education about osteoporosis after fragility fracture Canadian Journal of Hospital Pharmacy 59 184-193

[4] Cinats JG(2011)Bone mineral density changes in patients with recent-onset rheumatoid arthritis Clinical Medical Insights: Arthritis and Musculoskeletal Disorders 2011 87-94

[5] Hanley DA(2006)Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis Calcif Tissue Int 79 84-94

[6] Harley CH(2018)Depression and risk of fractures and bone loss: an updated meta-analysis of prospective studies Osteoporos Int 29 1303-1312

[7] Juby AG(2010)A review of the effect of anticonvulsant medications on bone mineral density and fracture risk Am J Geriatr Pharmacother 8 34-46

[8] Lier DA(2018)Association between chronic or acute use of antihypertensive class of medications and falls in older adults. A systematic review and meta-analysis Am J Hypertens 31 467-479

[9] Maksymowych WP(2018)Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service Osteoporos Int 29 397-407

[10] Majumdar SR(2016)Patterns of prescription drug use before and after fragility fracture JAMA Intern Med 176 1531-1538

[1] Morrish DW(2009)Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial Arthritis Rheum 61 209-215

[2] Beaupre LA(2004)A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture Ann Intern Med 141 366-373

[3] Bell NR(2006)Measuring the impact of pharmacist intervention: results of patient education about osteoporosis after fragility fracture Canadian Journal of Hospital Pharmacy 59 184-193

[4] Cinats JG(2011)Bone mineral density changes in patients with recent-onset rheumatoid arthritis Clinical Medical Insights: Arthritis and Musculoskeletal Disorders 2011 87-94

[5] Hanley DA(2006)Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis Calcif Tissue Int 79 84-94

[6] Harley CH(2018)Depression and risk of fractures and bone loss: an updated meta-analysis of prospective studies Osteoporos Int 29 1303-1312

[7] Juby AG(2010)A review of the effect of anticonvulsant medications on bone mineral density and fracture risk Am J Geriatr Pharmacother 8 34-46

[8] Lier DA(2018)Association between chronic or acute use of antihypertensive class of medications and falls in older adults. A systematic review and meta-analysis Am J Hypertens 31 467-479

[9] Maksymowych WP(2018)Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service Osteoporos Int 29 397-407

[10] Majumdar SR(2016)Patterns of prescription drug use before and after fragility fracture JAMA Intern Med 176 1531-1538